Last checked at 14 Jan 2019 07:00
14 January 2019
Benchmark Holdings plc
("Benchmark" or the "Company")
Notice of Preliminary Results
Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its preliminary results for the year ended 30 September 2018 on Thursday, 24 January 2019.
Malcolm Pye, Chief Executive Officer, Mark Plampin, Chief Financial Officer, and Alex Raeber, the recently appointed Chief Scientific Officer, will host a presentation for analysts on that day at 9.30am at the offices of Numis Securities, London Stock Exchange Building, 10 Paternoster Square, London, EC4M 7LT. To register your interest, please contact benchmark@mhpc.com.
Please note the change of venue to that stated in our previous announcement dated 7th November 2018.
Enquiries
Benchmark Holdings plc | Tel: 020 7920 3150 |
Malcolm Pye, CEO | |
Ivonne Cantu, Investor Relations Director | |
Rachel Aninakwah, Communications | |
Numis | Tel: 020 7260 1000 |
Michael Meade / Freddie Barnfield (NOMAD) | |
James Black (Corporate Broking) | |
MHP | |
Katie Hunt / Reg Hoare /Alistair de Kare-Silver | Tel: 020 3128 8742 benchmark@mhpc.com |
Notes to Editors:
Benchmark's mission is to drive sustainability in food production.
We are a leading provider of aquaculture solutions in genetics, health and specialist nutrition. Our focus is on developing innovative products that help fish and shrimp producers improve their sustainability and profitability by improving yield, quality, health and welfare. Our main products are salmon eggs with superior genetic traits, specialist nutrition products for shrimp and fish, and health treatments including a sea lice treatment for salmon. We serve all the major aquaculture markets around the world and have leading market positions. Benchmark operates in 27 countries, employs 1,066 people and reported revenues of £140m in 2017.
For further information on Benchmark please visit www.benchmarkplc.com